Table 4.
Screening Pre-Test Probability Cutpoint** |
Percent Screened^ |
Percent of Men with PVFx Detected |
Prevalence PVFx Among Those Screened |
|
---|---|---|---|---|
Model 1# | 5% | 68.1% | 81.1% | 8.7% |
10% | 18.6% | 34.5% | 13.6% | |
15% | 4.9% | 11.3% | 16.9% | |
Model 2& | 5% | 63.5% | 81.9% | 9.4% |
10% | 18.2% | 38.7% | 15.5% | |
15% | 6.4% | 15.1% | 17.3% | |
Model 3## | 5% | 60.5% | 81.4% | 9.7% |
10% | 18.6% | 39.8% | 15.5% | |
15% | 6.6% | 16.0% | 17.5% | |
Model 4&& | 5% | 60.5% | 81.2% | 9.7% |
10% | 19.1% | 42.0% | 15.9% | |
15% | 7.1% | 18.8% | 19.1% |
Prediction model used to determine who has lateral spine imaging to look for prevalent vertebral fracture
Pre-test probability of PVFx cutpoint at and above which lateral spine imaging would be done
Proportion above the cutpoint according to the prediction model who would have spine imaging
Model 1: Age and Femoral Neck BMD
Model 2: Age, Femoral Neck BMD, and historical height loss
Model 3: Age, Femoral Neck BMD, historical height loss, prior non-vertebral fracture, body mass index, presence of and limitations from back pain, and grip strength
Model 4: Age, Femoral Neck BMD, historical height loss, prior non-vertebral fracture, body mass index, presence of and limitations from back pain, grip strength, smoking, and glucocorticoid use
Analyses limited to men with did not self-report prior spine fracture at the baseline visit and with femoral neck BMD T-score ≤ −1.0